Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Neuromyelitis Optica (NMO) with Abdominal Tuberculosis (TB).
Microvesicles in the brain: Biomarker, messenger or mediator?
No association between body composition and cognition in ambulatory persons with multiple sclerosis: A brief report.
Improved Framework for Tractography Reconstruction of the Optic Radiation.
Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barré syndrome.
T cell chemokine receptor patterns as pathogenic signatures in autoimmunity.
The link between resting-state functional connectivity and cognition in MS patients.
Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Let's rehabilitate cognitive rehabilitation in multiple sclerosis.
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Strength: A Relevant Link to Functional Performance in the Neurodegenerative Disease of Adrenomyeloneuropathy.
Neuromyelitis optica.
Pregnancy and multiple sclerosis: the children of PRIMS.
Interferon-β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients.
Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Harnessing the integrated stress response for the treatment of multiple sclerosis.
Erratum to: Reassessing the risk of natalizumab-associated PML.
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.
Relation of Posterior Cerebellar Volume to Cognition in MS.
Multiple sclerosis: potential risk factors in childhood and adolescence.
Activation of oligodendroglial Stat3 is required for efficient remyelination.
The Role of Astrocytes in Multiple Sclerosis Progression.
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.
Pages
« first
‹ previous
…
684
685
686
687
688
689
690
691
692
…
next ›
last »